我们可以停止担心长期的PPI和胃癌风险吗?
Courtney M Richman1,2, David A Leiman3,4
1Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
概括
使用质子抑制剂 (PPI) 并没有长期增加胃癌风险. 短期使用PPI显示出潜在的联系,但这可能是由于反向因果关系,而不是直接风险.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 药学流行病学 药学流行病学
背景情况:
- 质子抑制剂 (PPI) 广泛用于消化系统疾病.
- 长期使用PPI会导致酸性抑制和高胃血.
- 关于PPI使用和胃癌风险的数据是相互矛盾的.
研究的目的:
- 调查PPI使用与胃癌风险之间的关联.
- 分析PPI使用时间及其对胃癌发病率的影响.
主要方法:
- 从胃癌聚合 (StoP) 项目的病例控制数据的聚合分析.
- 包括5项国际研究,其中组织学证实了胃癌.
- 利用了患者报告的PPI使用数据.
主要成果:
- 短期使用PPI (≤6个月) 与胃癌风险增加有关.
- 长期使用PPI (≥3年) 与胃癌风险没有显著关联.
- 没有特定的胃癌亚型与任何PPI使用有关.
结论:
- 在胃癌风险方面,长期使用PPI似乎是安全的.
- 与短期使用的关联可能是由于反向因果关系.
- 需要对H. pylori等混因子进行进一步的研究.
更多相关视频
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
469
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
469
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
400
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
400
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
493
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
493
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
515
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
515
Peptic Ulcer Disease I: Introduction
197
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
197


